Reuters

India's Indoco Remedies up on USFDA approval for diabetes drug

 Jun 6, 2024 at 9:57 am GMT

** Shares of Indoco Remedies INRM.NS climb 2.5% to 318 rupees

** Co gets tentative abbreviated new drug application approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets

** Drugs used to treat type 2 diabetes mellitus

** INRM set for a second session of gains, if trend holds

** Stock down ~19.5% so far this year